share_log

Rocket Pharmaceuticals Price Target Raised to $66.00/Share From $61.00 by SVB Leerink

Dow Jones Newswires ·  Apr 1, 2021 18:52

DJ Rocket Pharmaceuticals Is Maintained at Outperform by SVB Leerink

Ratings actions from Benzinga: https://www.benzinga.com/stock/RCKT/ratings

(END) Dow Jones Newswires

April 01, 2021 06:52 ET (10:52 GMT)

DJ Rocket Pharmaceuticals Price Target Raised to $66.00/Share From $61.00 by SVB Leerink

Ratings actions from Benzinga: https://www.benzinga.com/stock/RCKT/ratings

(END) Dow Jones Newswires

April 01, 2021 06:52 ET (10:52 GMT)

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment